Effects of sitagliptin on peritoneal membrane: The potential role of mesothelial cell tight junction proteins.

BACKGROUND The roles of tight junction (TJ) proteins in peritoneal membrane transport and peritoneal dialysis (PD) require further characterisation. Dipeptidyl peptidase-4 is expressed in mesothelial cells, and its activity may affect peritoneal membrane function and morphology. METHODS Human peritoneal mesothelial cells (HPMCs) were isolated and cultured from omentum obtained during abdominal surgery, and paracellular transport functions were evaluated by measuring transmesothelial electrical resistance (TMER) and dextran flux. Sprague-Dawley rats were infused daily with 4.25% peritoneal dialysate with and without sitagliptin administration for 8 weeks. At the end of this period, rat peritoneal mesothelial cells (RPMCs) were isolated to evaluate TJ protein expression. RESULTS In HPMCs, the protein expression of claudin-1, claudin-15, occludin and E-cadherin was decreased by TGF-β treatment but reversed by sitagliptin co-treatment. TMER was decreased by TGF-β treatment but improved by sitagliptin co-treatment. Consistent with this, dextran flux was increased by TGF-β treatment and reversed by sitagliptin co-treatment. In the animal experiment, sitagliptin-treated rats had a lower D2/D0 glucose ratio and a higher D2/P2 creatinine ratio than PD controls during the peritoneal equilibration test. Protein expression of claudin-1, claudin-15 and E-cadherin decreased in RPMCs from PD controls but was not affected in those from sitagliptin-treated rats. Peritoneal fibrosis was induced in PD controls but ameliorated in sitagliptin-treated rats. CONCLUSION The expression of TJ proteins including claudin-1 and claudin-15 was associated with transport function both in HPMCs and in a rat model of PD. Sitagliptin prevents peritoneal fibrosis in PD and can potentially restore peritoneal mesothelial cell TJ proteins.

[1]  G. Kim,et al.  Claudins in kidney health and disease , 2022, Kidney research and clinical practice.

[2]  J. Chiang,et al.  Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis , 2021, Communications biology.

[3]  D. Kang.  Loosening of the mesothelial barrier as an early therapeutic target to preserve peritoneal function in peritoneal dialysis , 2020, Kidney research and clinical practice.

[4]  G. Lang,et al.  Sitagliptin and the Blood-Retina Barrier: Effects on Retinal Endothelial Cells Manifested Only after Prolonged Exposure , 2020, Journal of diabetes research.

[5]  G. Sethi,et al.  The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges , 2019, Cells.

[6]  B. Gallwitz.  Clinical Use of DPP-4 Inhibitors , 2019, Front. Endocrinol..

[7]  W. Fang,et al.  Pharmacological inhibition of heparin-binding EGF-like growth factor promotes peritoneal angiogenesis in a peritoneal dialysis rat model , 2018, Clinical and Experimental Nephrology.

[8]  G. Kim,et al.  Roles of claudin-2, ZO-1 and occludin in leaky HK-2 cells , 2017, PloS one.

[9]  Sun-Hee Park,et al.  Metformin ameliorates the Phenotype Transition of Peritoneal Mesothelial Cells and Peritoneal Fibrosis via a modulation of Oxidative Stress , 2017, Scientific Reports.

[10]  Yan-yan Su,et al.  PPAR‑γ agonist rosiglitazone protects rat peritoneal mesothelial cells against peritoneal dialysis solution‑induced damage. , 2017, Molecular medicine reports.

[11]  A. Yu,et al.  Claudin‐2‐mediated cation and water transport share a common pore , 2017, Acta physiologica.

[12]  Rafael Rodríguez-Muñoz,et al.  Diabetes and exposure to peritoneal dialysis solutions alter tight junction proteins and glucose transporters of rat peritoneal mesothelial cells. , 2016, Life sciences.

[13]  A. Nakashima,et al.  Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice , 2016, PloS one.

[14]  J. Perl,et al.  Peritoneal dialysis: from bench to bedside and bedside to bench. , 2016, American journal of physiology. Renal physiology.

[15]  C. Ahn,et al.  HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis. , 2016, American journal of physiology. Renal physiology.

[16]  J. Reyes,et al.  Alterations of Intercellular Junctions in Peritoneal Mesothelial Cells from Patients Undergoing Dialysis: Effect of Retinoic Acid , 2015, Peritoneal Dialysis International.

[17]  S. Amasheh,et al.  Tight junction physiology of pleural mesothelium , 2014, Front. Physiol..

[18]  O. Devuyst,et al.  Water transport across the peritoneal membrane. , 2014, Kidney international.

[19]  S. Kang,et al.  Paricalcitol Ameliorates Epithelial-to-Mesenchymal Transition in the Peritoneal Mesothelium , 2014, Nephron Experimental Nephrology.

[20]  T. Chan,et al.  Pathophysiology of the Peritoneal Membrane during Peritoneal Dialysis: The Role of Hyaluronan , 2011, Journal of biomedicine & biotechnology.

[21]  J. van den Born,et al.  Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  M. Fromm,et al.  Claudin Tight Junction Proteins: Novel Aspects in Paracellular Transport , 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[23]  H. Kajiyama,et al.  Possible involvement of SDF-1α/CXCR4-DPPIV axis in TGF-β1-induced enhancement of migratory potential in human peritoneal mesothelial cells , 2007, Cell and Tissue Research.

[24]  Shinsuke Nomura,et al.  Intercellular localization of occludins and ZO-1 as a solute transport barrier of the mesothelial monolayer , 2006, Journal of Artificial Organs.

[25]  In‐San Kim,et al.  Effect of Glucose Degradation Products on the Peritoneal Membrane in a Chronic Inflammatory Infusion Model of Peritoneal Dialysis in the Rat , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[26]  N. Yorioka,et al.  Effect of Glucose Polymer on the Intercellular Junctions of Cultured Human Peritoneal Mesothelial Cells , 2003, Nephron Clinical Practice.

[27]  H. Kajiyama,et al.  Increased Expression of Dipeptidyl Peptidase IV in Human Mesothelial Cells by Malignant Ascites from Ovarian Carcinoma Patients , 2002, Oncology.

[28]  F. Marumo,et al.  Expression of Aquaporin-1 in the Peritoneal Tissues: Localization and Regulation by Hyperosmolality , 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[29]  S. Davies,et al.  Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.